OrthoSpace - Acquired by Stryker (NYSE:SYE)

📍 Caesarea, Israel🗓 Founded 2009👥 13 employees💰 Last funded 2011
Orthospace Ltd develops and commercializes simple-to-implant, biodegradable balloon systems for the Orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures. The company’s first product- the InSpace™ System is indicated for Rotator Cuff syndrome as it alleviates pain in patients. The InSpace™ System has the CE mark and is commercially available in Europe. In the USA, the InSpace is an investigational device. Limited by Federal (or United States) law to investigational use. Exclusively for clinical investigations.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2009
Founded
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in OrthoSpace - Acquired by Stryker (NYSE:SYE)?
OrthoSpace - Acquired by Stryker (NYSE:SYE) has 1 investors on record on gritt.io, including 1 early-stage backers.
When did OrthoSpace - Acquired by Stryker (NYSE:SYE) last raise funding?
The most recent investment in OrthoSpace - Acquired by Stryker (NYSE:SYE) recorded on gritt.io was in 2011.
When was OrthoSpace - Acquired by Stryker (NYSE:SYE) founded?
OrthoSpace - Acquired by Stryker (NYSE:SYE) was founded in 2009.
What industry is OrthoSpace - Acquired by Stryker (NYSE:SYE) in?
OrthoSpace - Acquired by Stryker (NYSE:SYE) operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is OrthoSpace - Acquired by Stryker (NYSE:SYE) based?
OrthoSpace - Acquired by Stryker (NYSE:SYE) is headquartered in Caesarea, Israel.